Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

被引:497
作者
Livnah, O
Stura, EA
Middleton, SA
Johnson, DL
Jolliffe, LK
Wilson, LA
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA
关键词
D O I
10.1126/science.283.5404.987
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Erythropoietin receptor (EPOR) is thought to be activated by Ligand-induced homodimerization. However, structures of agonist and antagonist peptide complexes of EPOR, as well as an EPO-EPOR complex, have shown that the actual dimer configuration is critical for the biological response and signal efficiency. The crystal structure of the extracellular domain of EPOR in its unliganded form at 2.4 angstrom resolution has revealed a dimer in which the individual membrane-spanning and intracellular domains would be too far apart to permit phosphorylation by JAK2. This unliganded EPOR dimer is formed from self-association of the same key binding site residues that interact with EPO-mimetic peptide and EPO Ligands. This model for a preformed dimer on the cell surface provides insights into the organization, activation, and plasticity of recognition of hematopoietic cell surface receptors.
引用
收藏
页码:987 / 990
页数:4
相关论文
共 54 条
  • [21] ERYTHROPOIETIN RECEPTOR - APPLICATION IN DRUG DEVELOPMENT
    JOLLIFFE, LK
    MIDDLETON, SA
    BARBONE, FP
    JOHNSON, DL
    MCMAHON, FJ
    LEE, WH
    GRUNINGER, RH
    MULCAHY, LS
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 28 - 34
  • [22] IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS
    JONES, TA
    ZOU, JY
    COWAN, SW
    KJELDGAARD, M
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 : 110 - 119
  • [23] KRANTZ SB, 1991, BLOOD, V77, P419
  • [24] Dimerization of the synaptic vesicle protein synaptobrevin (vesicle-associated membrane protein) II depends on specific residues within the transmembrane segment
    Laage, R
    Langosch, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (02): : 540 - 546
  • [25] Dimerisation of the glycophorin a transmembrane segment in membranes probed with the ToxR transcription activator
    Langosch, D
    Brosig, B
    Kolmar, H
    Fritz, HJ
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 263 (04) : 525 - 530
  • [26] PROCHECK - A PROGRAM TO CHECK THE STEREOCHEMICAL QUALITY OF PROTEIN STRUCTURES
    LASKOWSKI, RA
    MACARTHUR, MW
    MOSS, DS
    THORNTON, JM
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 : 283 - 291
  • [27] Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 angstrom
    Livnah, O
    Stura, EA
    Johnson, DL
    Middleton, SA
    Mulcahy, LS
    Wrighton, NC
    Dower, WJ
    Jolliffe, LK
    Wilson, IA
    [J]. SCIENCE, 1996, 273 (5274) : 464 - 471
  • [28] An antagonist peptide EPO receptor complex suggests that receptor dimerization is not sufficient for activation
    Livnah, O
    Johnson, DL
    Stura, EA
    Farrell, FX
    Barbone, FP
    You, Y
    Liu, KD
    Goldsmith, MA
    He, W
    Krause, CD
    Pestka, S
    Jolliffe, LK
    Wilson, IA
    [J]. NATURE STRUCTURAL BIOLOGY, 1998, 5 (11) : 993 - 1004
  • [29] A sequential dimerization mechanism for erythropoietin receptor activation
    Matthews, DJ
    Topping, RS
    Cass, RT
    Giebel, LB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) : 9471 - 9476
  • [30] Identification of a critical ligand binding determinant of the human erythropoietin receptor - Evidence for common ligand binding motifs in the cytokine receptor family
    Middleton, SA
    Johnson, DL
    Jin, RZ
    McMahon, FJ
    Collins, A
    Tullai, J
    Gruninger, RH
    Jolliffe, LK
    Mulcahy, LS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 14045 - 14054